Bio

Dean joined GTCR in 2001 and is currently a Managing Director of the firm. Prior to joining GTCR, Dean was CEO and co-founder of Delray Farms, LLC, a specialty food retailer. Prior to that, Dean was with McKinsey & Company. Dean holds an MBA with distinction from the Harvard Business School and a BS with high distinction in finance and economics from the University of Illinois, Chicago. Dean is head of the Healthcare group at GTCR and has been instrumental in building the firm’s expertise in pharma, life sciences and medical devices. He is currently a Director of Albany Molecular, Antylia Scientific, Ceba-Tech, Cedar Gate Technologies, Corza Health, Maravai LifeSciences, Riverchase Dermatology, Regatta Medical, Rx30, Sotera and TerSera. Dean was previously a Director of past GTCR investments, including Actient Pharmaceuticals, ATI Physical Therapy, Convergex, Cord Blood Registry, Crealta Pharmaceuticals, Curo Health Services, Dash, Devicor Medical Products, GreatCall, Ovation Pharmaceuticals, Managed Healthcare Associates and XIFIN. Dean was highly involved with Chicago Public Media for over 10 years, serving as a board member and Chair of the Finance Committee.